Hazardous drug safety

Learn about the dangers of hazardous drug exposure―they are studied, documented and very real

About 75,000 Canadian healthcare workers, including pharmacists, pharmacy technicians, nurses and other caregivers are potentially exposed to hazardous drugs, according to Carex Canada.1 This exposure is putting them at risk of both short- and long-term health issues such as headaches, hair loss, nausea, organ damage, reproductive problems,2 developmental impairment, genetic issues and even cancer.3

To address these risks, healthcare facilities need to comply with new and existing standards, guidelines and recommendations. Closed system transfer devices (CSTDs) are recommended as part of a comprehensive safety system. They can help reduce environmental contamination and exposure for a safer environment for staff, patients and visitors.

Why BD hazardous drug safety?

When selecting a CSTD solution, you need to protect your team. But we know that is not your only concern. With the BD PhaSeal system, the Texium system and an array of services—all designed to help you reduce the risk of hazardous drug exposure, you can obtain a tailored solution that balances your needs for safety, efficiency and cost.


BD HD Check system

The BD HD Check system detects hazardous drug contamination on multiple surfaces and locations.


BD PhaSeal system

The BD PhaSeal system is airtight and leakproof to protect your staff from hazardous drug exposure during drug preparation, administration and disposal.


Texium system

Our Texium system is an end-to-end closed system that integrates the drug preparation and delivery process.


Browse all hazardous drug safety products

You can view all of our hazardous drug safety products, and search by different selections and criteria.

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

 BD-2062 (3/17)

  1. Carex Canada 2018, Antineoplastic Agents, Occupational Estimate, https://www.carexcanada.ca/en/antineoplastic_agents/occupational_estimate/
  2. Connor TH, Lawson CC, Polovich M, McDiarmid MA. Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med. 2014;56(9):901-910.
  3. Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20(1):22-26.


This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.